한글목차

오베티콜산 시장 규모는 최근 급성장하고 있습니다. 2025년 10억 1,000만 달러에서 2026년에는 11억 4,000만 달러에 이르고, CAGR 12.9%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 원발성 담즙성 담관염 치료제의 임상 승인, 간질환 진단 증가, 간 전문 클리닉의 확대, 담즙산 조절 요법에 대한 인식 개선, 간 전문 의약품의 성장에 기인하는 것으로 보입니다.

오베티콜산 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 18억 4,000만 달러에 이르고, CAGR은 12.7%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 NASH 환자 수 증가, 간질환 치료제 파이프라인 확대, 진단 스크리닝 도입의 진전, 간질환 연구에 대한 투자 확대, 경구용 간 치료제의 세계 보급 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 만성 간질환 유병률 증가, FXR 작용제 치료제의 도입 확대, 질환 조절 간 치료제에 대한 관심 증가, 비알콜성 지방간염(NASH) 연구 확대, 경구용 간 치료제 사용 증가 등을 꼽을 수 있습니다.

간 질환의 발생률 증가는 향후 몇 년 동안 오베티콜산 수요 증가를 견인할 것으로 예측됩니다. 간질환이란 간의 정상적인 기능을 손상시키는 질환군입니다. 이러한 간 질환 증가는 주로 과도한 알코올 섭취에 기인하며, 간세포를 손상시키고 장기 기능 저하를 초래하여 간염, 간경변, 간부전을 유발할 수 있습니다. 오베티콜산은 파네소이드 X 수용체(FXR)를 활성화시켜 간질환 환자에게 도움을 줍니다. 이는 담즙산 축적을 억제하고, 간 염증을 감소시키며, 섬유화 진행을 지연시키고, 궁극적으로 간 기능을 향상시킵니다. 예를 들어, 2024년 12월 영국 정부 기관인 건강 개선 및 격차 대책국이 발표한 보고서에 따르면, 알코올성 간질환으로 인한 조기 사망자 수는 2023년 3.6% 증가하여 5,984명(2022년 5,776명)에 이르렀다고 합니다. 이처럼 간질환의 유병률 증가가 오베티콜산 시장 확대에 기여하고 있습니다.

오베티콜산 분야의 주요 기업들은 간질환 관리를 강화하고 환자 예후를 개선하기 위해 파네소이드 X 수용체(FXR) 작용제 등 혁신적인 치료법 개발에 집중하고 있습니다. 파네소이드 X 수용체(FXR) 작용제는 간에서 담즙산 대사, 염증, 섬유화 조절에 중요한 역할을 하는 핵 내 수용체인 FXR을 자극하는 화합물입니다. FXR 작용제는 간 기능 개선에 기여하며, 원발성 담즙성 담관염(PBC), 비알코올성 지방간염(NASH) 등의 치료에 활용되고 있습니다. 예를 들어, 2024년 2월에는 미국 바이오제약 기업 인터셉트 파마슈티컬스(Intercept Pharmaceuticals)가 원발성 담즙성 담관염(PBC) 치료제 오칼리바(Ocaliva)의 추가신약허가신청(sNDA)을 미국 식품의약국(FDA)이 승인했다고 발표했습니다. 발표하였습니다. 오베티콜산(오칼리바)의 추가신약허가신청(sNDA)이 FDA에 의해 승인된 것은 원발성 담즙성 담관염(PBC) 치료에 대한 임상적 유효성을 확인하는 데 있어 중요한 규제적 진전을 이룬 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Obeticholic acid is a drug mainly prescribed for managing liver conditions, particularly in patients with primary biliary cholangitis (PBC), a long-term liver disorder. It is a synthetic bile acid that functions by stimulating a receptor known as the farnesoid X receptor (FXR), which aids in controlling bile acid synthesis, supporting liver function, and reducing inflammation.

The primary product forms of obeticholic acid include tablets, capsules, and other variants. Tablets are solid dosage forms intended for easy oral administration. The drug is distributed through multiple channels such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to manage nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

Tariffs have affected the obeticholic acid market by increasing the cost of imported active pharmaceutical ingredients, intermediates, and excipients used in bile acid-based therapies. These impacts have been most pronounced in specialty liver drug segments, particularly in north america and europe. Asia-pacific manufacturers have faced procurement delays and cost pressures. However, tariffs have supported localized API production and formulation, improving supply continuity.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including obeticholic acid industry global market size, regional shares, competitors with a obeticholic acid market share, detailed obeticholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical approval for primary biliary cholangitis treatment, rising liver disease diagnosis, expansion of hepatology clinics, increased awareness of bile acid regulation therapies, growth in specialty liver drugs.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing NASH patient population, expansion of liver disease drug pipelines, improved diagnostic screening adoption, rising investment in hepatology research, global expansion of oral liver therapies. Major trends in the forecast period include rising prevalence of chronic liver diseases, increasing adoption of FXR agonist therapies, growing focus on disease-modifying liver drugs, expansion of nonalcoholic steatohepatitis research, increasing use of oral hepatology treatments.

The increasing incidence of liver diseases is expected to drive the demand for obeticholic acid in the coming years. Liver diseases are disorders that impair the liver's normal functioning. This rise in liver diseases is primarily attributed to excessive alcohol consumption, which can cause liver inflammation, cirrhosis, and liver failure by damaging liver cells and reducing the organ's ability to operate effectively. Obeticholic acid aids patients with liver diseases by activating the farnesoid X receptor (FXR), which lowers bile acid accumulation, diminishes liver inflammation, and slows the progression of fibrosis, ultimately enhancing liver function. For example, in December 2024, the Office for Health Improvement and Disparities, a UK government department, reported that premature deaths from alcoholic liver disease rose by 3.6% in 2023, reaching 5,984, up from 5,776 in 2022. Consequently, the growing prevalence of liver diseases is contributing to the expansion of the obeticholic acid market.

Major companies operating in the obeticholic acid sector are focusing on developing innovative therapies, such as farnesoid X receptor (FXR) agonists, to enhance liver disease management and improve patient outcomes. A farnesoid X receptor (FXR) agonist is a compound that stimulates the FXR, a nuclear receptor that plays a key role in regulating bile acid metabolism, inflammation, and fibrosis in the liver. Farnesoid X receptor (FXR) agonists aid in improving liver function and are utilized in treating conditions like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For example, in February 2024, Intercept Pharmaceuticals Inc., a US-based biopharmaceutical firm, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat patients with primary biliary cholangitis (PBC). The FDA's acceptance of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) represents a regulatory milestone toward confirming its clinical benefits in managing PBC.

In November 2023, Alfasigma, a pharmaceutical company based in Italy, acquired Intercept Pharmaceuticals, Inc. for USD 19.00 per share in cash. Through this acquisition, Alfasigma seeks to enhance its presence in the U.S. and broaden its portfolio in gastroenterology and hepatology. Intercept Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company dedicated to developing therapies for rare and serious liver diseases, including primary biliary cholangitis (PBC), with its leading product being Ocaliva.

Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Immediate-Release Tablets; Modified-Release Tablets; Film-Coated Tablets
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
• Subsegments:
• 1) By Immediate-Release Tablets: Standard Oral Tablets; Low-Dose Strength Tablets
• 2) By Modified-Release Tablets: Controlled Exposure Tablets; Once-Daily Optimized Release Tablets
• 3) By Film-Coated Tablets: Taste-Masked Tablets; Gastrointestinal-Tolerant Tablets
• Companies Mentioned: Intercept Pharmaceuticals Inc.; Genfit; Gilead Sciences Inc.; Pfizer Inc.; Bayer AG; Sumitomo Dainippon Pharma Co. Ltd.; Horizon Therapeutics; Alembic Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Lupin Limited; Zydus Cadila; Teva Pharmaceutical Industries Ltd.; WuXi AppTec; Viva Life Sciences; Omgene Life Sciences Pvt. Ltd.; Enanta Pharmaceuticals; Novo Nordisk A/S; AstraZeneca plc; Roche Holding AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Obeticholic Acid Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Obeticholic Acid Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Obeticholic Acid Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Obeticholic Acid Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Prevalence Of Chronic Liver Diseases
  • 4.2.2 Increasing Adoption Of Fxr Agonist Therapies
  • 4.2.3 Growing Focus On Disease-Modifying Liver Drugs
  • 4.2.4 Expansion Of Nonalcoholic Steatohepatitis Research
  • 4.2.5 Increasing Use Of Oral Hepatology Treatments

5. Obeticholic Acid Market Analysis Of End Use Industries

• 5.1 Hepatology Hospitals
• 5.2 Specialty Liver Clinics
• 5.3 Tertiary Care Hospitals
• 5.4 Gastroenterology Centers
• 5.5 Specialty Pharmacies

6. Obeticholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Obeticholic Acid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Obeticholic Acid Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Obeticholic Acid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Obeticholic Acid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Obeticholic Acid Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Obeticholic Acid Market Segmentation

• 9.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets
• 9.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
• 9.4. Global Obeticholic Acid Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Oral Tablets, Low-Dose Strength Tablets
• 9.5. Global Obeticholic Acid Market, Sub-Segmentation Of Modified-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Controlled Exposure Tablets, Once-Daily Optimized Release Tablets
• 9.6. Global Obeticholic Acid Market, Sub-Segmentation Of Film-Coated Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets

10. Obeticholic Acid Market Regional And Country Analysis

• 10.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Obeticholic Acid Market

• 11.1. Asia-Pacific Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Obeticholic Acid Market

• 12.1. China Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Obeticholic Acid Market

• 13.1. India Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Obeticholic Acid Market

• 14.1. Japan Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Obeticholic Acid Market

• 15.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Obeticholic Acid Market

• 16.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Obeticholic Acid Market

• 17.1. South Korea Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Obeticholic Acid Market

• 18.1. Taiwan Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Obeticholic Acid Market

• 19.1. South East Asia Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Obeticholic Acid Market

• 20.1. Western Europe Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Obeticholic Acid Market

• 21.1. UK Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Obeticholic Acid Market

• 22.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Obeticholic Acid Market

• 23.1. France Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Obeticholic Acid Market

• 24.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Obeticholic Acid Market

• 25.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Obeticholic Acid Market

• 26.1. Eastern Europe Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Obeticholic Acid Market

• 27.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Obeticholic Acid Market

• 28.1. North America Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Obeticholic Acid Market

• 29.1. USA Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Obeticholic Acid Market

• 30.1. Canada Obeticholic Acid Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Obeticholic Acid Market

• 31.1. South America Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Obeticholic Acid Market

• 32.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Obeticholic Acid Market

• 33.1. Middle East Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Obeticholic Acid Market

• 34.1. Africa Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Obeticholic Acid Market Regulatory and Investment Landscape

36. Obeticholic Acid Market Competitive Landscape And Company Profiles

• 36.1. Obeticholic Acid Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Obeticholic Acid Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Obeticholic Acid Market Company Profiles
  • 36.3.1. Intercept Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Genfit Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Obeticholic Acid Market Other Major And Innovative Companies

• Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

38. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Obeticholic Acid Market

40. Obeticholic Acid Market High Potential Countries, Segments and Strategies

• 40.1 Obeticholic Acid Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Obeticholic Acid Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Obeticholic Acid Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer